Royalty Pharma plc (RPRX) Net income 2018–2025
Royalty Pharma plc (RPRX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$770.9MFY2025 · since FY2018: $1.4B → $770.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $770.9M | -10.2% |
| FY2024 | $859.0M | -24.3% |
| FY2023 | $1.1B | +2549.5% |
| FY2022 | $42.8M | -93.1% |
| FY2021 | $619.7M | -36.4% |
| FY2020 | $975.0M | -58.5% |
| FY2019 | $2.3B | +70.5% |
| FY2018 | $1.4B | — |
Source: SEC XBRL filings · For reference only · Not investment advice